#London #United Kingdom #Life Sciences #Clarivate #DRG Fusion

Clarivate Launches DRG Fusion

Clarivate Plc has taken a significant step forward in the life sciences sector with the introduction of its innovative platform, DRG Fusion. This new analytics product is designed specifically for commercial teams within biopharma and medtech organizations, enabling them to harness real-world data to optimize their strategies and improve patient outcomes.

Understanding DRG Fusion

DRG Fusion addresses a pressing challenge that many organizations face today: the extraction of valuable insights from fragmented data sources. In a rapidly changing market, biopharma and medtech companies need actionable insights to navigate competitive pressures and shifting demands. Fusion streamlines this process by integrating medical and pharmacy claims, among other real-world data sources, simplifying data management and eliminating the complexities often associated with raw data.

With user-tested workflows and continuously refreshed data, teams can easily identify gaps in product positioning and uncover new opportunities to enhance patient acquisition and retention. The platform offers modular solutions tailored to the specific needs of sales and marketing teams, providing pre-built modules that allow for configurable dashboards.

Features and Benefits

Abeezer Tapia, Senior Vice President and General Manager of Real-World Data at Clarivate, highlighted the four key workflows that Fusion offers. These workflows focus on essential objectives such as sizing and segmenting target patient populations, identifying leakage points in the patient journey, deploying sales teams based on precise targeting, and designing supportive value messages to optimize access.

What sets Fusion apart is its focus on mastering data at both the drug and device levels. This targeted approach is crucial for informed decision-making in biopharma and medtech sectors, ensuring that commercial strategies align with real-world outcomes.

Henry Levy, President of Life Sciences Healthcare at Clarivate, emphasized the robustness of their life sciences data and its wide-ranging commercial applications. The scalable architecture of Fusion is meticulously crafted to deliver rapid insights across various patient diseases and sub-population cohorts, thus addressing some of healthcare's most pressing challenges.

In addition to its current capabilities, future releases will introduce AI-driven features and self-service options, further enhancing the user experience and expanding the platform's capabilities.

Streamlined Data Management

Fusion not only simplifies complex data analysis but also provides ready-made, visual analytics that facilitate faster commercial decision-making. By leveraging this platform, life sciences organizations can expect to accelerate their product launch and growth strategies while simultaneously improving patient outcomes.

Conclusion

For those looking to optimize their approach in the life sciences arena, DRG Fusion presents an invaluable tool. By integrating real-world data and offering user-centric solutions, Clarivate aims to empower organizations to navigate the complexities of healthcare more effectively.

To discover more about this innovative analytics platform, including how it can transform your strategies, you can visit Clarivate. Their commitment to enhancing product value through data-driven insights continues to push the boundaries of what's possible in the life sciences industry.